Document:

Unassociated Document

    Amended
      

    

    2004
      STOCK OPTION PLAN,

    

    OF

    

    ROO
      GROUP, INC.

    

    

    
      	
              1.

            	
              PURPOSES
                OF THE PLAN 

            

    

    

    The
      purposes of the 2004 Stock Option Plan (the “Plan”) of ROO Group, Inc., a
      Delaware corporation (the “Company”), are to: 

    

    (a) Encourage
      selected employees, directors and consultants to improve operations and increase
      profits of the Company;

    

    (b) Encourage
      selected employees, directors and consultants to accept or continue employment
      or association with the Company or its Affiliates; and 

    

    (c) Increase
      the interest of selected employees, directors and consultants in the Company's
      welfare through participation in the growth in value of the common stock of
      the
      Company (the “Shares”).

    

    Options
      granted under this Plan (“Options”) may be “incentive stock options” (“ISOs”)
      intended to satisfy the requirements of Section 422 of the Internal Revenue
      Code
      of 1986, as amended, and the regulations thereunder (the “Code”), or
“non-qualified stock options” (“NQSOs”). 

    

    
      	
              2.

            	
              ELIGIBLE
                PERSONS 

            

    

    

    Every
      person who at the date of grant of an Option is an employee of the Company
      or of
      any Affiliate (as defined below) of the Company is eligible to receive NQSOs
      or
      ISOs under this Plan. Every person who at the date of grant is a consultant
      to,
      or non-employee director of, the Company or any Affiliate (as defined below)
      of
      the Company is eligible to receive NQSOs under this Plan. The term “Affiliate”
as used in the Plan means a parent or subsidiary corporation as defined in
      the
      applicable provisions (currently Sections 424(e) and (f), respectively) of
      the
      Code. The term “employee” includes an officer or director who is an employee of
      the Company. The term “consultant” includes persons employed by, or otherwise
      affiliated with, a consultant. 

    

    
      	
              3.

            	
              STOCK
                SUBJECT TO THIS PLAN; MAXIMUM NUMBER OF GRANTS

            

    

    

    Subject
      to the provisions of Section 6.1.1 of the Plan, the total number of Shares
      which
      may be issued under Options granted pursuant to this Plan shall not exceed
      Twelve million (12,000,000) Shares. The Shares covered by the portion of any
      grant under the Plan which expires unexercised shall become available again
      for
      grants under the Plan. 

    

    
      	
              4.

            	
              ADMINISTRATION

            

    

    

    (a) The
      Plan
      shall be administered by either the Board of Directors of the Company (the
      “Board”) or by a committee (the “Committee”) to which administration of the
      Plan, or of part of the Plan, may be delegated by the Board (in either case,
      the
“Administrator”). The Board shall appoint and remove members of such Committee,
      if any, in its discretion in accordance with applicable laws. If necessary
      in
      order to comply with Rule 16b-3 under the Securities Exchange Act of 1934,
      as
      amended (the “Exchange Act”) and Section 162(m) of the Code, the Committee
      shall, in the Board's discretion, be comprised solely of “non-employee
      directors” within the meaning of said Rule 16b-3 and “outside directors” within
      the meaning of Section 162(m) of the Code. The foregoing notwithstanding, the
      Administrator may delegate nondiscretionary administrative duties to such
      employees of the Company as it deems proper and the Board, in its absolute
      discretion, may at any time and from time to time exercise any and all rights
      and duties of the Administrator under the Plan. 

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    (b) Subject
      to the other provisions of this Plan, the Administrator shall have the
      authority, in its discretion: (i) to grant Options; (ii) to determine the fair
      market value of the Shares subject to Options; (iii) to determine the exercise
      price of Options granted; (iv) to determine the persons to whom, and the time
      or
      times at which, Options shall be granted, and the number of shares subject
      to
      each Option; (v) to interpret this Plan; (vi) to prescribe, amend, and rescind
      rules and regulations relating to this Plan; (vii) to determine the terms and
      provisions of each Option granted (which need not be identical), including
      but
      not limited to, the time or times at which Options shall be exercisable; (viii)
      with the consent of the optionee, to modify or amend any Option; (ix) to defer
      (with the consent of the optionee) the exercise date of any Option; (x) to
      authorize any person to execute on behalf of the Company any instrument
      evidencing the grant of an Option; and (xi) to make all other determinations
      deemed necessary or advisable for the administration of this Plan. The
      Administrator may delegate nondiscretionary administrative duties to such
      employees of the Company as it deems proper. 

    

    (c) All
      questions of interpretation, implementation, and application of this Plan shall
      be determined by the Administrator. Such determinations shall be final and
      binding on all persons. 

    

    
      	
              5.

            	
              GRANTING
                OF OPTIONS; OPTION AGREEMENT 

            

    

    

    (a) No
      Options shall be granted under this Plan after 10 years from the date of
      adoption of this Plan by the Board. 

    

    (b) Each
      Option shall be evidenced by a written stock option agreement, in form
      satisfactory to the Administrator, executed by the Company and the person to
      whom such Option is granted. 

    

    (c) The
      stock
      option agreement shall specify whether each Option it evidences is an NQSO
      or an
      ISO. 

    

    (d) Subject
      to Section 6.3.3 with respect to ISOs, the Administrator may approve the grant
      of Options under this Plan to persons who are expected to become employees,
      directors or consultants of the Company, but are not employees, directors or
      consultants at the date of approval, and the date of approval shall be deemed
      to
      be the date of grant unless otherwise specified by the Administrator.

    

    
      	
              6.

            	
              TERMS
                AND CONDITIONS OF OPTIONS 

            

    

    

    Each
      Option granted under this Plan shall be subject to the terms and conditions
      set
      forth in Section 6.1. NQSOs shall also be subject to the terms and conditions
      set forth in Section 6.2, but not those set forth in Section 6.3. ISOs shall
      also be subject to the terms and conditions set forth in Section 6.3, but not
      those set forth in Section 6.2. 

    

    6.1 Terms
      and
      Conditions to Which All Options Are Subject. All Options granted under this
      Plan
      shall be subject to the following terms and conditions: 

    

    6.1.1 Changes
      in Capital Structure. Subject to Section 6.1.2, if the stock of the Company
      is
      changed by reason of a stock split, reverse stock split, stock dividend, or
      recapitalization, combination or reclassification, appropriate adjustments
      shall
      be made by the Board in (a) the number and class of shares of stock subject
      to
      this Plan and each Option outstanding under this Plan, and (b) the exercise
      price of each outstanding Option; provided, however, that the Company shall
      not
      be required to issue fractional shares as a result of any such adjustments.
      Each
      such adjustment shall be subject to approval by the Board in its sole
      discretion. 

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    6.1.2 Change
      in
      Control. Upon the closing of a change in control transaction, as defined below,
      the Vesting Base Date of all outstanding options shall be accelerated by twelve
      (12) months. A Change in Control means,
      and
      shall be deemed to have occurred upon the occurrence of, any one of the
      following events: 

    

    (a) The
      acquisition in one or more transactions by any individual, entity or group
      (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a
      "Person") of beneficial ownership (within the meaning of Rule l3d-3 promulgated
      under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) of
      shares or other securities (as defined in Section 3(a)(10) of the Exchange
      Act)
      representing 40% or more of outstanding Stock; provided, however, that a Change
      in Control as defined in this clause (a) shall not be deemed to occur in
      connection with any acquisition by the Company, an employee benefit plan of
      the
      Company or any Person who immediately prior to the effective date of this Plan
      is a holder of Stock (a "Current Stockholder") so long as such acquisition
      does
      not result in any Person other than the Company, such employee benefit plan
      or
      such Current Stockholder beneficially owning shares or securities representing
      40% or more of the outstanding Stock; or

    

    (b) Any
      election has occurred of persons as directors of the Company that causes
      two-thirds or more of the Board to consist of persons other than (i) persons
      who, were members of the Board on the effective date of this Plan and (ii)
      persons who were nominated by the Board for election as members of the Board
      at
      a time when at least two-thirds of the Board consisted of persons who were
      members of the Board on the effective date of this Plan; provided, however,
      that
      any person nominated for election by the Board when at least two-thirds of
      the
      members of the Board are persons described in subclause (i) or (ii) and persons
      who were themselves previously nominated in accordance with this clause (b)
      shall, for this purpose, be deemed to have been nominated by a Board composed
      of
      persons described in subclause (ii); or 

    

    (c) Approval
      by the stockholders of the Company of a reorganization, merger, consolidation
      or
      similar transaction (a "Reorganization Transaction"), in each case, unless,
      immediately following such Reorganization Transaction, more than 50% of,
      respectively, the outstanding shares of common stock (or similar equity
      security) of the corporation or other entity resulting from or surviving such
      Reorganization Transaction and the combined voting power of the securities
      of
      such corporation or other entity entitled to vote generally in the election
      of
      directors, is then beneficially owned, directly or indirectly, by the
      individuals and entities who were the respective beneficial owners of the
      outstanding Stock immediately prior to such Reorganization Transaction in
      substantially the same proportions as their ownership of the outstanding Stock
      immediately prior to such Reorganization Transaction; or 

    

    (d) Approval
      by the stockholders of the Company of (i) a complete liquidation or dissolution
      of the Company or (ii) the sale or other disposition of all or substantially
      all
      of the assets of the Company to a corporation or other entity, unless, with
      respect to such corporation or other entity, immediately following such sale
      or
      other disposition more than 50% of, respectively, the outstanding shares of
      common stock (or similar equity security) of such corporation or other entity
      and the combined voting power of the securities of such corporation or other
      entity entitled to vote generally in the election of directors, is then
      beneficially owned, directly or indirectly, by the individuals and entities
      who
      were the respective beneficial owners of the outstanding Stock immediately
      prior
      to such sale or disposition in substantially the same proportions as their
      ownership of the outstanding Stock immediately prior to such sale or
      disposition.

    

    6.1.3 Time
      of
      Option Exercise. Subject to Section 5 and Section 6.3.4, Options granted under
      this Plan shall be exercisable (a) immediately as of the effective date of
      the
      stock option agreement granting the Option, or (b) in accordance with a schedule
      as may be set by the Administrator (each such date on such schedule, the
“Vesting Base Date”) and specified in the written stock option agreement
      relating to such Option. In any case, no Option shall be exercisable until
      a
      written stock option agreement in form satisfactory to the Company is executed
      by the Company and the optionee. 

    

    6.1.4 Option
      Grant Date. The date of grant of an Option under this Plan shall be the date
      as
      of which the Administrator approves the grant. 

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    6.1.5 Nontransferability
      of Option Rights. Except with the express written approval of the Administrator
      which approval the Administrator is authorized to give only with respect to
      NQSOs, no Option granted under this Plan shall be assignable or otherwise
      transferable by the optionee except by will, by the laws of descent and
      distribution or pursuant to a qualified domestic relations order. During the
      life of the optionee, an Option shall be exercisable only by the optionee.
      

    

    6.1.6 Payment.
      Except as provided below, payment in full, in cash, shall be made for all stock
      purchased at the time written notice of exercise of an Option is given to the
      Company, and proceeds of any payment shall constitute general funds of the
      Company. The Administrator, in the exercise of its absolute discretion, may
      authorize any one or more of the following additional methods of payment:

    

    (a) Subject
      to the discretion of the Administrator and the terms of the stock option
      agreement granting the Option, delivery by the optionee of Shares already owned
      by the optionee for all or part of the Option price, provided the fair market
      value (determined as set forth in Section 6.1.10) of such Shares being delivered
      is equal on the date of exercise to the Option price, or such portion thereof
      as
      the optionee is authorized to pay by delivery of such stock; and 

    

    (b) Subject
      to the discretion of the Administrator, through the surrender of Shares then
      issuable upon exercise of the Option, provided the fair market value (determined
      as set forth in Section 6.1.10) of such Shares is equal on the date of exercise
      to the Option price, or such portion thereof as the optionee is authorized
      to
      pay by surrender of such stock. 

    

    6.1.7 Termination
      of Employment. If for any reason other than death or permanent and total
      disability, an optionee ceases to be employed by the Company or any of its
      Affiliates (such event being called a “Termination”), Options held at the date
      of Termination (to the extent then exercisable) may be exercised in whole or
      in
      part at any time within three months of the date of such Termination, or such
      other period of not less than 30 days after the date of such Termination as
      is
      specified in the Option Agreement or by amendment thereof (but in no event
      after
      the Expiration Date); provided, however, that if such exercise of the Option
      would result in liability for the optionee under Section 16(b) of the Exchange
      Act, then such three-month period automatically shall be extended until the
      tenth day following the last date upon which optionee has any liability under
      Section 16(b) (but in no event after the Expiration Date). If an optionee dies
      or becomes permanently and totally disabled (within the meaning of Section
      22(e)(3) of the Code) while employed by the Company or an Affiliate or within
      the period that the Option remains exercisable after Termination, Options then
      held (to the extent then exercisable) may be exercised, in whole or in part,
      by
      the optionee, by the optionee's personal representative or by the person to
      whom
      the Option is transferred by devise or the laws of descent and distribution,
      at
      any time within twelve months after the death or twelve months after the
      permanent and total disability of the optionee or any longer period specified
      in
      the Option Agreement or by amendment thereof (but in no event after the
      Expiration Date). For purposes of this Section 6.1.7, “employment” includes
      service as a director or as a consultant. For purposes of this Section 6.1.7,
      an
      optionee's employment shall not be deemed to terminate by reason of sick leave,
      military leave or other leave of absence approved by the Administrator, if
      the
      period of any such leave does not exceed 90 days or, if longer, if the
      optionee's right to reemployment by the Company or any Affiliate is guaranteed
      either contractually or by statute. 

     

    After
      the
      occurrence of a change in control transaction, as defined in 6.1.2, if any
      optionee’s employment is terminated without cause or their job responsibilities
      are materially altered, then all options held by such optionee that have not
      yet
      vested shall immediately vest. For purposes of this section 6.1.7, an optionee’s
      responsibilities shall be determined to be materially altered if there is a
      material reduction of optionee’s title, authority, duties or responsibilities,
      or the assignment to optionee of duties materially inconsistent with optionee’s
      positions with the Company. 

    

    6.1.8 Withholding
      and Employment Taxes. At the time of exercise of an Option and as a condition
      thereto, or at such other time as the amount of such obligations becomes
      determinable (the “Tax Date”), the optionee shall remit to the Company in cash
      all applicable federal and state withholding and employment taxes. Such
      obligation to remit may be satisfied, if authorized by the Administrator in
      its
      sole discretion, after considering any tax, accounting and financial
      consequences, by the optionee's (i) delivery of a promissory note in the
      required amount on such terms as the Administrator deems appropriate, (ii)
      tendering to the Company previously owned Shares or other securities of the
      Company with a fair market value equal to the required amount, or (iii) agreeing
      to have Shares (with a fair market value equal to the required amount) which
      are
      acquired upon exercise of the Option withheld by the Company. 

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    6.1.9 Other
      Provisions. Each Option granted under this Plan may contain such other terms,
      provisions, and conditions not inconsistent with this Plan as may be determined
      by the Administrator, and each ISO granted under this Plan shall include such
      provisions and conditions as are necessary to qualify the Option as an
“incentive stock option” within the meaning of Section 422 of the Code.

    

    6.1.10 Determination
      of Value. For purposes of the Plan, the fair market value of Shares or other
      securities of the Company shall be determined as follows: 

    

    (a) Fair
      market value shall be the closing price of such stock on the date before the
      date the value is to be determined on the principal recognized securities
      exchange or recognized securities market on which such stock is reported, but
      if
      selling prices are not reported, its fair market value shall be the mean between
      the high bid and low asked prices for such stock on the date before the date
      the
      value is to be determined (or if there are no quoted prices for such date,
      then
      for the last preceding business day on which there were quoted prices).

    

    (b) In
      the
      absence of an established market for the stock, the fair market value thereof
      shall be determined in good faith by the Administrator, with reference to the
      Company's net worth, prospective earning power, dividend-paying capacity, and
      other relevant factors, including the goodwill of the Company, the economic
      outlook in the Company's industry, the Company's position in the industry,
      the
      Company's management, and the values of stock of other corporations in the
      same
      or similar line of business. 

    

    6.1.11 Option
      Term. Subject to Section 6.3.4, no Option shall be exercisable more than 10
      years after the date of grant, or such lesser period of time as is set forth
      in
      the stock option agreement (the end of the maximum exercise period stated in
      the
      stock option agreement is referred to in this Plan as the “Expiration Date”).

    

    6.2 Terms
      and
      Conditions to Which Only NQSOs Are Subject. Options granted under this Plan
      which are designated as NQSOs shall be subject to the following terms and
      conditions: 

    

    6.2.1 Exercise
      Price.

    

    (a) Except
      as
      set forth in Section 6.2.1(b), the exercise price of an NQSO shall be not less
      than 85% of the fair market value (determined in accordance with Section 6.1.10)
      of the stock subject to the Option on the date of grant. 

    

    (b) To
      the
      extent required by applicable laws, rules and regulations, the exercise price
      of
      a NQSO granted to any person who owns, directly or by attribution under the
      Code
      (currently Section 424(d)), stock possessing more than ten percent of the total
      combined voting power of all classes of stock of the Company or of any Affiliate
      (a “Ten Percent Shareholder”) shall in no event be less than 110% of the fair
      market value (determined in accordance with Section 6.1.10) of the stock covered
      by the Option at the time the Option is granted. 

    

    6.3 Terms
      and
      Conditions to Which Only ISOs Are Subject. Options granted under this Plan
      which
      are designated as ISOs shall be subject to the following terms and conditions:
      

    

    6.3.1 Exercise
      Price.

    

    
      
         

      

      
         

        
          

        

      

      
         

      

       

    

    (a) Except
      as
      set forth in Section 6.3.1(b), the exercise price of an ISO shall be determined
      in accordance with the applicable provisions of the Code and shall in no event
      be less than the fair market value (determined in accordance with Section
      6.1.10) of the stock covered by the Option at the time the Option is granted.
      

    

    (b) The
      exercise price of an ISO granted to any Ten Percent Shareholder shall in no
      event be less than 110% of the fair market value (determined in accordance
      with
      Section 6.1.10) of the stock covered by the Option at the time the Option is
      granted.

    

    6.3.2 Disqualifying
      Dispositions. If stock acquired by exercise of an ISO granted pursuant to this
      Plan is disposed of in a “disqualifying disposition” within the meaning of
      Section 422 of the Code (a disposition within two years from the date of grant
      of the Option or within one year after the transfer of such stock on exercise
      of
      the Option), the holder of the stock immediately before the disposition shall
      promptly notify the Company in writing of the date and terms of the disposition
      and shall provide such other information regarding the Option as the Company
      may
      reasonably require. 

    

    6.3.3 Grant
      Date. If an ISO is granted in anticipation of employment as provided in Section
      5(d), the Option shall be deemed granted, without further approval, on the
      date
      the grantee assumes the employment relationship forming the basis for such
      grant, and, in addition, satisfies all requirements of this Plan for Options
      granted on that date. 

    

    6.3.4 Term.
      Notwithstanding Section 6.1.11, no ISO granted to any Ten Percent Shareholder
      shall be exercisable more than five years after the date of grant. 

    

    
      	
              7.

            	
              MANNER
                OF EXERCISE

            

    

    

    (a) An
      optionee wishing to exercise an Option shall give written notice to the Company
      at its principal executive office, to the attention of the officer of the
      Company designated by the Administrator, accompanied by payment of the exercise
      price and withholding taxes as provided in Sections 6.1.6 and 6.1.8. The date
      the Company receives written notice of an exercise hereunder accompanied by
      payment of the exercise price will be considered as the date such Option was
      exercised.

     

    (b) Promptly
      after receipt of written notice of exercise of an Option and the payments called
      for by Section 7(a), the Company shall, without stock issue or transfer taxes
      to
      the optionee or other person entitled to exercise the Option, deliver to the
      optionee or such other person a certificate or certificates for the requisite
      number of shares of stock. An optionee or permitted transferee of the Option
      shall not have any privileges as a shareholder with respect to any shares of
      stock covered by the Option until the date of issuance (as evidenced by the
      appropriate entry on the books of the Company or a duly authorized transfer
      agent) of such shares. 

    

    
      	
              8.

            	
              EMPLOYMENT
                OR CONSULTING RELATIONSHIP

            

    

    

    Nothing
      in this Plan or any Option granted hereunder shall interfere with or limit
      in
      any way the right of the Company or of any of its Affiliates to terminate any
      optionee's employment or consulting at any time, nor confer upon any optionee
      any right to continue in the employ of, or consult with, the Company or any
      of
      its Affiliates. 

    

    
      	
              9.

            	
              CONDITIONS
                UPON ISSUANCE OF SHARES 

            

    

    

    Shares
      shall not be issued pursuant to the exercise of an Option unless the exercise
      of
      such Option and the issuance and delivery of such shares pursuant thereto shall
      comply with all relevant provisions of law, including, without limitation,
      the
      Securities Act of 1933, as amended (the “Securities Act”). 

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    
 

    
      	
              10.

            	
              NON-EXCLUSIVITY
                OF THE PLAN 

            

    

    

    The
      adoption of the Plan shall not be construed as creating any limitations on
      the
      power of the Company to adopt such other incentive arrangements as it may deem
      desirable, including, without limitation, the granting of stock options other
      than under the Plan.

    

    11.   AMENDMENTS
      TO PLAN

    

    The
      Board
      may at any time amend, alter, suspend or discontinue this Plan. Without the
      consent of an optionee, no amendment, alteration, suspension or discontinuance
      may adversely affect outstanding Options except to conform this Plan and ISOs
      granted under this Plan to the requirements of federal or other tax laws
      relating to incentive stock options. No amendment, alteration, suspension or
      discontinuance shall require shareholder approval unless (a) shareholder
      approval is required to preserve incentive stock option treatment for federal
      income tax purposes or (b) the Board otherwise concludes that shareholder
      approval is advisable. 

    

    12.   EFFECTIVE
      DATE OF PLAN; TERMINATION

    

    This
      Plan
      shall become effective upon adoption by the Board; provided, however, that
      no
      Option shall be exercisable unless and until written consent of the shareholders
      of the Company, or approval of shareholders of the Company voting at a validly
      called shareholders' meeting, is obtained within twelve months after adoption
      by
      the Board. If such shareholder approval is not obtained within such time,
      Options granted hereunder shall be of the same force and effect as if such
      approval was obtained except that all ISOs granted hereunder shall be treated
      as
      NQSOs. Options may be granted and exercised under this Plan only after there
      has
      been compliance with all applicable federal and state securities laws. This
      Plan
      shall terminate within ten years from the date of its adoption by the
      Board.Exhibit 10.97

                         EXECUTIVE EMPLOYMENT AGREEMENT
                         ------------------------------

         THIS EMPLOYMENT AGREEMENT (the "Agreement") is entered into as of the
21st day of March, 2007 by and between Gene Logic Inc., a Delaware corporation
(the "Company"), and Charles L. Dimmler III (the "Executive").

         The Company desires to secure the services of Executive and Executive
desires to perform such services for the Company on the terms and conditions as
set forth in this Agreement.

NOW, THEREFORE, in consideration of the mutual promises made below, the parties
agree as follows:

         1. Employment, Duties and Acceptance.

                  1.1.  Employment. (a) Effective as of March 21, 2007 (the
"Effective Date"), the Company shall employ the Executive as the Chief Executive
Officer ("CEO") of the Company. In such capacity, the Executive shall perform
such executive and management duties and assume such other responsibilities as
may be assigned from time to time by the Board of Directors and that are
appropriate to his role as CEO. The Executive accepts such employment and shall
perform his duties faithfully and to the best of his abilities.

                  (b) The Executive shall devote his full working time and
creative energies to the performance of his duties hereunder and will at all
times devote such time and efforts as are reasonably sufficient for fulfilling
the significant responsibilities entrusted to him. So long as such activities,
in the aggregate, do not interfere in a material way with the performance by the
Executive of his duties hereunder, the Executive shall be permitted a reasonable
amount of time to (i) supervise his and his family's personal, passive
investments and (ii) participate (as board member, officer or volunteer) in
civic, political and charitable activities. If the Executive wishes to undertake
any other outside activities, including any activities for which he would
receive compensation in any form, the Executive must obtain prior written
approval of the Chairman of the Board of Directors.

                  1.2.  Place of Employment. The Executive's principal place of
employment shall be at the Company's headquarters in the Baltimore-Washington,
D.C. metropolitan area (including Montgomery, Howard and Frederick Counties in
Maryland), subject to such travel as may be reasonably required by his
employment pursuant to the terms hereof. The Executive shall not be required to
relocate to the principal place of employment until March 31, 2008. After that
date, the Executive and the Chairman of the Board of Directors shall discuss the
relocation of the Executive to an appropriate location (the greater Washington
or the greater Boston area) and the Company will provide relocation benefits
reasonably acceptable to the Company and the Executive.

         2. Term of Employment. The Executive's term of employment with the
Company (the "Term") shall commence on the Effective Date and continue
thereafter on an at-will basis until terminated by either party pursuant to
Section 4, subject to certain rights upon termination as provided in Section 4.
If Executive's employment hereunder with the Company is terminated by the
Executive or by the Company, Executive shall thereby be removed from, and
Executive agrees to resign immediately from, all other positions with the
Company and its affiliates and subsidiaries (collectively the "GLGC Group"),
including but not limited to resigning from the Board of Directors.

         3. Compensation.

                  3.1.  Salary. As compensation for all services to be rendered
pursuant to this Agreement, the Company shall pay to the Executive during the
Term a salary at the rate of $425,000 per annum (the "Base Salary") less such
deductions as shall be required to be withheld by applicable tax and other laws
and regulations or as otherwise authorized by the Executive. The Base Salary
shall accrue from and after the Effective Date, and shall be payable during the
Term, in arrears in equal periodic installments, not less frequently than
semi-monthly. The Executive's Base Salary shall be reviewed annually and may be
increased or decreased based upon various factors, including the Board's or the
Compensation Committee's evaluation of the Executive's performance and the
compensation policies of the Company in effect at the time of each such review.
The Base Salary shall be prorated for the first calendar year of employment and
for any other year in which Executive is not employed by the Company for the
entire year based on the portion of the year in which Executive is employed on a
full-time basis by the Company.

<PAGE>
Exhibit 10.97

                  3.2.  Incentive Compensation. Executive will be eligible to
participate in any incentive compensation plan established by the Company's
Board of Directors (the "Board") or the Compensation Committee of the Board (the
"Compensation Committee") and generally applicable to officers of the Company.
Payment of incentive compensation under any such plan will be contingent on
achieving such targets and levels of performance as are specified by the
Compensation Committee. Incentive compensation payments for any applicable plan
will be made on the terms specified in the plan, subject to prior approval by
the Compensation Committee. The target incentive compensation for Executive for
the Company's fiscal year 2007, which shall be based on achieving 100% of the
targets and levels of performance established by the Compensation Committee,
will be 40% of the base salary specified in Section 3.1 of this Agreement, for a
full calendar year, less applicable withholding, prorated based on the portion
of the year in which Executive is employed by the Company. To receive incentive
compensation for any period, except as specifically provided in section 4.7, the
Executive must be employed by the Company on a full-time basis as of the last
business day of the period for which the incentive compensation is paid.

                  3.3.  Equity Awards. Upon and subject to approval by the Board
of Directors of the Company, the Board's Compensation Committee or anyone
properly designated by such Committee to approve such award, Executive will
receive the following equity awards under the Company's 1997 Equity Incentive
Plan (the "Plan"):

     o    a grant of an option for 120,000 shares of Common Stock, exercisable
          at an exercise price equal to the fair market value on the date of
          grant, vesting in four equal increments of 30,000 shares each, with
          the first increment vesting on the date of grant and each subsequent
          increment vesting on each of the next three anniversaries of the date
          of grant.

     o    a grant of 50,000 shares of restricted stock vesting on March 21,
          2008, the first anniversary of the Executive's appointment as CEO.

and such other equity awards as may be agreed to from time to time.

The options will have a 10-year term and all of the equity grants will be
subject to the other terms and conditions of the Plan and the standard form of
stock option and restricted stock grant agreements thereunder. The stock option
will be an incentive stock option under Section 422 of the Internal Revenue Code
of 1986, as amended, ("Code") to the maximum extent permitted by the law and the
Plan; any remaining portion of the stock option will be treated as a
Non-Statutory Stock Option.

                  3.4.  Participation in Benefit Plans. The Executive shall be
permitted during the Term, to the extent eligible, to participate in any group
life, medical, dental, vision, or disability insurance plans, accidental death
and dismemberment plan, 401(k) plan, or similar benefit plans of the Company
which may be available generally to other senior executives of the Company, but
nothing herein shall prevent the Company from adding to, changing or eliminating
such benefits from time to time.

                  3.5.  Paid Time Off. The Executive shall accrue and may use
paid time off ("PTO") in accordance with the Company's policies. PTO accruing in
the first calendar year of employment and in any other year in which Executive
is not employed by the Company for the entire year shall be prorated based on
the portion of the year in which Executive is employed by the Company.

                  3.6.  Holidays. The Executive shall be eligible for holidays
in accordance with the Company's policy and schedule.

<PAGE>
Exhibit 10.97

                  3.7.  Expenses. In accordance with the Company's policies, the
Executive will be reimbursed for all ordinary, necessary and reasonable business
expenses (including, without limitation, travel, meetings, dues, subscriptions,
fees, educational expenses, and expenses incurred for operation of mobile
telephones,) actually incurred or paid by the Executive during the Term in the
proper performance of the Executive's services under this Agreement, upon
presentation of expense statements or vouchers or such other supporting
information as the Company or Board may reasonably require.

During the period March 21, 2007until March 21, 2008 (or such earlier time as is
determined by the Board of Directors in accordance with Exhibit A)),
reimbursable expenses will include the Executive's cost of commuting to and from
his principal residence to the Company's locations in Gaithersburg and
Cambridge, for meals and temporary lodging while working at these locations and
for a $400 per month car allowance to lease a vehicle in Gaithersburg.

                  3.8.  [intentionally omitted]

                  3.9.  Withholding. The Company is authorized to withhold from
the amount of any Base Salary and bonuses and any other payments or benefits
paid or provided to or for the benefit of the Executive, all sums authorized by
the Executive or required to be withheld by law, court decree, or executive
order, including (but not limited to) such things as income taxes, employment
taxes, and employee contributions to fringe benefit plans sponsored by the
Company.

                  3.10. Change of Control. The Executive shall be included in
the Company's Executive Severance Plan (the "Change-of-Control Severance Plan"),
which provides certain benefits if the Executive's employment is terminated in
connection with a change in control of the Company, provided that for purposes
of calculating "the annual maximum bonus award that the Eligible Employee is
eligible to receive as of the Termination Date" for 2007 in Section 3(a)(i) of
that plan, the executive's 2007 target incentive compensation shall not be
prorated.

         4. Termination.

                  4.1.  General. The employment of the Executive hereunder may
be terminated as provided in this Section 4.

                  4.2.  Termination Upon Mutual Agreement. The Company and the
Executive may, by mutual written agreement, terminate this Agreement and/or the
employment of the Executive at any time.

                  4.3.  Death or Disability of Executive.

                  (a) The employment of the Executive hereunder shall terminate
upon (i) the death of the Executive, or (ii) at the option of the Company upon
not less than thirty (30) days prior written notice to the Executive or his
personal representative or guardian, if the Executive suffers a Total Disability
(as defined in Section 4.3(b) below).

                  (b) For purposes of this Agreement, "Total Disability" shall
mean (i) if the Executive is subject to a legal decree of incompetency (the date
of such decree being deemed the date on which such disability occurred), or (ii)
the written determination by a physician reasonably selected by the Company and
reasonably acceptable to the Executive or his personal representative or
guardian that, because of a medically determinable disease, injury or other
physical or mental disability, the Executive is substantially unable to perform
his essential duties, without reasonable accommodation, and that such disability
has lasted for the immediately preceding ninety (90) days and is, as of the date
of written determination, reasonably expected to last an additional ninety (90)
days or longer after the date of determination. If requested by the Company,
Executive agrees to appear at a medical examination by a physician reasonably
selected by the Company and to furnish to such physician such medical
information as is reasonably needed for a determination under this Section
4.3(b). Nothing in this provision is intended to restrict rights or obligations
under the Americans with Disabilities Act or other applicable law.

<PAGE>
Exhibit 10.97

                  (c) Any leave on account of illness or temporary disability
which is short of Total Disability shall not constitute a breach of this
Agreement by the Executive and in no event shall any party be entitled to
terminate this Agreement for Cause (as defined below) due to any such leave. All
physicians selected hereunder shall be Board certified in the appropriate
specialty most closely related to the nature of the disability alleged to exist.

                  4.4. Termination For Cause. The Company may, upon action of
the Board and upon written notice to the Executive specifying in reasonable
detail the reason therefore, terminate the employment of the Executive at any
time for Cause (as defined in Attachment A); provided, however, that if the
reason for termination for Cause is susceptible of cure as determined by the
Company, the Executive shall have a period of fifteen (15) business days after
such written notice to effect a cure satisfactory to the Company and, if so
cured, such termination in such instance shall be deemed withdrawn, but any such
withdrawal shall not affect the right of the Company to initiate a termination
for any other cause or in any other instance, including a recurrence of the
circumstances that led to the initial decision to terminate .

                  4.5.  Termination Without Cause. The Company may also
terminate the employment of the Executive without Cause upon 30 days advance
written notice to the Executive, which termination shall constitute a
"Termination Without Cause". Termination without Cause shall not include a
termination due to death or Total Disability. The Company may limit the
activities of the Executive on behalf of the Company during such thirty day
period or assign transitional or other duties not inconsistent with the position
held by the Executive or provide pay in lieu of such notice.

                  4.6.  Termination by Executive. The Executive may resign (and
thereby terminate his employment under this Agreement) at any time, by giving
the Company not less than thirty (30) days' prior written notice to the Company,
but the Company after receipt of such notice, may waive all or part of such
notice period, provided that the Company shall pay the Executive salary for such
notice period, whether or not waived.

                  4.7.  Payments Upon Termination Without Cause.

                  (a) If Executive's employment is terminated by the Company
without Cause, the Company shall pay the Executive

                        (i) Severance pay of twelve (12) months base salary,
payable in a single lump sum within fifteen (15) days after receipt of the
signed release described in subsection (b) below and expiration of any period
allowed for revocation of that release. This amount is in addition to and not in
lieu of base salary for the period prior to termination of employment made to
fulfill any requirement under the Agreement for prior notice of termination of
up to 30 days or pay in lieu thereof.

                        (ii) Reimbursement or, at the Company's option, direct
payment by the Company of that portion of the group health insurance premium for
post-employment coverage (including without limitation medical, dental and
vision coverage) for which Executive is eligible, and which the Executive timely
elects under COBRA because of his prior employment by Company, equal to the
percentage of the premium that Company was paying as of the last day of
Executive's employment by Company, for a period equal to the lesser of (x)
twelve (12) months or (y) until Executive becomes eligible for coverage under a
new employer's group health plan. Such reimbursement or direct payment will also
include coverage for any dependents of Executive who are eligible for, and
timely elect, coverage under COBRA for the same period as Executive equal to the
percentage of the premium for dependent coverage that Company was paying as of
the last day of Executive's employment by Company. Such reimbursement or direct
payment is for a period that is part of, and not in addition to, the total
period of eligibility for continuation of health insurance benefits to which
Executive, and/or the covered dependents, are entitled under COBRA.

                        If the option selected by the Company is reimbursement,
such reimbursement will be provided within a reasonable time following receipt
by the Company of confirmation of payment of the cost of such health insurance
by Executive (and, if applicable, covered dependents) for the number of weeks

<PAGE>
Exhibit 10.97

covered. Executive (and, if applicable, covered dependents) may request periodic
reimbursement, but not more often than monthly. Any such reimbursement must be
requested by Executive (and, if applicable, covered dependents) no later than
thirty (30) days following the end of the calendar year in which occurred the
due date for the respective premium and, if timely requested by Executive (and,
if applicable, covered dependents), will be reimbursed by Company no later than
thirty (30) days following receipt of the reimbursement request.

                        If the option selected by the Company is direct payment,
the Executive (and, if applicable, covered dependents) must pay to the Company
the Executive's (and, if applicable, covered dependents) portion of the COBRA
premium no later than the first of each month for which COBRA coverage is
continued.

                        (iii) Outplacement services paid for and through a
program and vendor selected by Company and at a level appropriate for an
executive for a period not to exceed six (6) months, and in no event costing
more than twenty thousand dollars ($20,000.00), to be used and completed within
twelve (12) months after termination of employment, unless otherwise agreed in
writing by Company, but in no event later than the end of the second calendar
year following the year of termination. Executive may not elect any payment in
lieu of such outplacement services and such services will only become available
after any release required under subsection (b) below is signed and the
revocation period specified therein has been completed without revocation

                  (b) Any payments made under this Section 4.7 will be
conditioned upon execution by Executive of a comprehensive and full release of
all claims arising from or connected with his employment by the Company in such
form as may be specified by the Company (excluding from any such release any
rights Executive may have to (x) indemnification or to insurance coverage with
respect to his actions while employed by the Company, whether by contract, under
Directors and officers or other insurance maintained by the Company or under the
Company's indemnification policies and agreements and applicable law concerning
indemnification, (y) coverage at the Executive's expense under applicable heath
care policies to the extent Executive is entitled to continued coverage under
COBRA) and (z) payment of compensation earned but not paid prior to
termination). Such release shall be presented to Executive as soon as
practicable and in any event no later than ten (10) days following Executive's
termination of employment. The release must be signed and returned to Company by
Executive no later than twenty-one (21) days after Executive's receipt of the
release, or such longer time limit stated in the release, and must not be
revoked within the period allowed for revocation as stated in the release in
order for Executive to become entitled to the severance and other benefits
hereunder.

                  (c) Notwithstanding anything to the contrary above, if the
Executive is eligible for and has met the conditions for receiving cash
severance and benefits under the Change-of-Control Severance Plan, then the
provisions set forth in the Change-of-Control Severance Plan shall apply in lieu
of severance and benefits under this Agreement, including without limitation
this Section 4.7. If Executive becomes entitled to cash severance and other
benefits under the Change-of-Control Severance Plan after receiving severance or
other benefits under this Agreement, the severance and other benefits under this
Agreement shall be credited against the cash severance and benefits due under
the Change-of-Control Severance Plan. In no event shall the aggregate severance
and other benefits actually paid and provided to Executive exceed the greater of
the amount payable under this Agreement, including without limitation this
Section 4.7, and or under the Change-of-Control Severance Plan as the result of
a termination of Executive's employment.

                  (d) The Company shall have no further liability to the
Executive pursuant to this Agreement, in the event of termination by the Company
in a Termination Without Cause except as set forth in this Section 4.7
including, without limitation, any liability to pay the Executive any severance,
bonus or any other compensation.

                  (e) The Company also waives, releases and remises (A) any
obligation or duty under applicable law on the part of the Executive to seek or
obtain other engagements or employment or to otherwise mitigate any damages to
which the Executive may be entitled by reason of any termination of this
Agreement; and (B) any right in or claim to any remuneration or compensation
received by Executive pursuant to any engagements or employment subsequent to
the termination of this Agreement.

<PAGE>
Exhibit 10.97

                  4.8.  Payments upon Termination for Cause or due to Death or
Disability of the Executive

                  (a) If the Executive's employment is terminated (i) by the
Company for Cause, or (ii) by the Executive, then the Company shall have no duty
to make any payments or provide any benefits to the Executive pursuant to this
Agreement other than payment of the amount of the Executive's Base Salary and
benefits accrued through the date of termination of his employment.

                  (b) Upon termination of Executive's employment for death or
Total Disability, the Company shall pay to the Executive, or to his guardian or
personal representative, as the case may be, in addition to any insurance or
disability benefits to which he may be entitled under applicable insurance and
benefit programs contemplated by Section 3.4 and then in effect, all amounts
accrued or vested prior to such termination; provided, however, if cash
severance benefits are payable under the Change-of-Control Severance Plan as a
result of such termination, then the provisions set forth in such plan shall
apply in lieu of the foregoing. The Company shall have no further liability to
the Executive, guardian or personal representative pursuant to this Agreement,
including, without limitation, any liability to pay the Executive, guardian or
personal representative any severance, bonus or any other compensation.

                  4.9.  No Disparaging Comments Upon Termination.

                  Upon termination of this Agreement and thereafter, the
Executive shall refrain from making any disparaging remarks about the
businesses, services, products, stockholders, officers, directors or other
personnel of the GLGC Group.

         5. Certain Covenants of the Executive.

                  5.1.  Necessity for Covenants. The Executive acknowledges that
(i) the GLGC Group (as defined below) is engaged and will in the future be
engaged in the Business as defined below in this Agreement; (ii) his employment
pursuant to this Agreement will give him access to customers and suppliers of
the GLGC Group; (iii) his employment will give him access to confidential
information and other trade secrets concerning the GLGC Group's products,
services and the Business and (iv) the agreements and covenants contained in
this Section 5 are essential to protect the business and goodwill of the GLGC
Group. As additional consideration for the Company's entering into this
Agreement and paying the compensation and other benefits at the levels requested
by the Executive, the Executive enters into the following covenants:

                  5.2.  Definitions.

                  (a) "Business" for purposes of this Article 5 shall mean the
provision by the GLGC Group of genomic information and bioinformatics products
and services and drug repositioning services to the pharmaceutical and
biotechnology industry. The Business includes

                        (i) biosample collection, handling and processing,
genomic data production and analysis, and data management and software systems
development, to create a broad range of gene expression-based information
solutions that facilitate the drug discovery and development process,

                        (ii) drug repositioning and drug indication seeking
programs conducted by the Company either for itself or with partners, and

                        (iii) any other products and services offered from time
to time by the GLGC Group as described in its annual and quarterly reports filed
with the Securities and Exchange Commission.

                  (b) "GLGC Group" for purposes of this Article 5 shall include
the Company, and all of its wholly or majority owned subsidiaries and affiliates
and successors and assigns of any of the foregoing.

                  (c) "Business Contact" shall mean any (i) customer which has
purchased goods or services provided by the GLGC Group during the Term, (ii)
prospective customer whom the Executive or persons working for or directly with

<PAGE>
Exhibit 10.97

the Executive has contacted during the Term for the purpose of endeavoring to
sell the goods or services of the GLGC Group to the prospective customer, or
(iii) provider of goods, services or technology that are material to the GLGC
Group.

                  (d) "Service Area" means North America, Western Europe and
Japan.

                  (e) "Term" means the term of employment as specified in
Section 2 hereof

                  5.3.  Restrictive Covenants.

                        5.3.1 Restrictions. During the Term and for a period of
one (1) year  after the date (the "Termination Date") the Executive's employment
hereunder is terminated (the "Restricted Period") regardless of whether such
termination is voluntary or involuntary, with or without Cause or by
resignation, the Executive shall not, directly or indirectly, for himself or on
behalf of any other person, firm, corporation or other entity, whether as a
principal, agent, employee, stockholder, partner, officer, member, adviser,
consultant, director, sole proprietor, or otherwise:

                  (a) call upon or solicit any Business Contact for the purpose
of persuading the Business Contact to engage the Executive or any other person,
firm, corporation or other entity to provide goods or services which are the
same as or similar to those the GLGC Group provided or proposed to provide to
the Business Contact or to engage the Business Contact to provide to any other
person, firm, corporation or other entity goods or services which are the same
as or similar to those the Business Contact provided to the GLGC Group;

                  (b) solicit, participate in or promote the solicitation of any
person who was employed by the GLGC Group at any time during the twelve (12)
months preceding the Termination Date to leave the employ of the GLGC Group, or
hire or engage or assist anyone to hire or engage any of those persons;

                  (c) make any disparaging remarks about the GLGC Group's
Business, services or personnel in any manner that is likely to have an adverse
effect on the GLGC Group's Business, services or personnel, provided that
Executive may respond accurately and fully to any questions, inquiry or request
for information when required by legal process or in response to an inquiry from
an administrative agency.;

                  (d) interfere in any way with the Business, prospects or
personnel of the GLGC Group in existence prior to the Termination Date or
contemplated by the GLGC Group during such period; or

                  (e) render services in any capacity (other than services
unrelated to the Business) to, or become affiliated with, any person, company or
other entity engaged in any business that competes with the Business within the
Service Area;

provided, however, that the Executive may own, directly or indirectly, solely as
an investment, securities which are publicly traded if the Executive (a) is not
a controlling person of, or a member of a group which controls, the issuer and
(b) does not, directly or indirectly, own 5% or more of any class of securities
of the issuer.

                        5.3.2 Severability of Covenants. The Executive
acknowledges and agrees that the Restrictive Covenants are reasonable and valid
in geographical and temporal scope and in all respects. If any court determines
that any of the Restrictive Covenants, or any part thereof, is invalid or
unenforceable, the remainder of the Restrictive Covenants shall not thereby be
affected and shall be given full effect, without regard to the invalid portions.

                        5.3.3 Blue-Penciling. If any court determines that any
of the Restrictive Covenants, or any part thereof, is unenforceable because of
the duration or geographic scope of such provision, such court shall have the
power to reduce the duration or scope of such provision, as the case may be,
and, in its reduced form, such provision shall then be enforceable and shall be
enforced. If any such court declines to so revise such covenant, the parties
agree to negotiate in good faith a modification that will make such duration or
scope enforceable.

<PAGE>
Exhibit 10.97

                  5.4.  Rights and Remedies Upon Breach. If the Executive
breaches, or threatens to commit a breach of, any of the provisions of Section
5.3 (the "Restrictive Covenants"), the Company shall, in addition to its right
immediately to terminate this Agreement for Cause, have the right and remedy
(which right and remedy shall be independent of others and severally
enforceable, and which shall be in addition to, and not in lieu of, any other
rights and remedies available to the Company under law or in equity) to have the
Restrictive Covenants specifically enforced by any court having jurisdiction, it
being acknowledged and agreed that any such breach or threatened breach could
cause irreparable injury to the Company and that money damages may not provide
an adequate remedy to the Company.

         6. Representations of Executive. The Executive represents and warrants
that:
                  (a) his employment by the Company will not (i) violate any
non-disclosure agreements, covenants against competition, or other restrictive
covenants or agreements made by the Executive with, to or for the benefit of any
previous employer or partner, or (ii) violate or constitute a breach or default
under, any statute, law, judgment, order, decree, writ, injunction, deed,
instrument, contract, lease, license or permit to which the Executive is a party
or by which the Executive is bound;

                  (b) there is no litigation, proceeding or investigation of any
nature (either civil or criminal) which is pending or, to the best of the
Executive's knowledge, threatened against or affecting the Executive or which
would adversely affect his ability to substantially perform the duties herein;
and
                  (c) he has received or been given the opportunity to review
the provisions of this Agreement, and the meaning and effect of each provision,
with independent legal counsel of the Executive's choosing.

         7. Confidentiality and Proprietary Inventions Agreement. As a condition
to his employment by the Company, the Executive agrees to enter into and be
bound by the provisions set forth in the Company's Proprietary Information and
Inventions Agreement, which is expressly incorporated by reference thereto.

         8. Dispute Resolution.

                  8.1.  Arbitration Policy. Subject to the Company's right to
seek injunctive or other equitable relief as specified in Section 5.4 of this
Agreement or in the Proprietary Information and Inventions Agreement, the
Parties agree that arbitration is the required and exclusive forum for the
resolution of any and all disputes between them, including claims arising under
statute, common law, or this Agreement. This mandatory arbitration provision
includes without limitation any claims or actions under Title VII of the Civil
Rights Act of 1964, the Civil Rights Act of 1866 ("Section 1981"), the Americans
with Disabilities Act, the Family and Medical Leave Act, the Age Discrimination
in Employment Act, the Fair Labor Standards Act, the Equal Pay Act, the Employee
Retirement Income Security Act, and any other federal, state or local statute,
law or regulation regarding employment, employment discrimination, terms and
conditions of employment, compensation or termination of employment. This
mandatory arbitration provision includes any dispute between the Executive and
the Company or its parents, subsidiaries and affiliates, and its and their
current and former officers, directors, employees and agents.

                  Any covered dispute must be submitted to arbitration in
accordance with the National Rules for the Resolution of Employment Disputes of
the American Arbitration Association. Any such arbitration will be conducted in
Montgomery County, Maryland, and will be decided in accordance with and
determined by the laws of the State of Maryland and/or applicable federal law.
The Executive specifically agrees that the Company may seek specific performance
of this provision, as well as other injunctive relief, from the state or federal
courts in Maryland. The arbitrator shall not have the authority to award
punitive damages, costs or attorneys' fees to either Party except where
expressly provided for by the applicable law.

                  Except as otherwise provided by applicable law, the
administrative costs of the arbitration (filing fees, cost for the arbitration
site, other AAA fees, arbitrator's fee) shall be divided equally between the
parties. In the event that the National Rules for the Resolution of Employment
Disputes of the American Arbitration Association, any express statutory
provisions, or controlling case law conflicts with this allocation and requires
the payment of administrative costs of arbitration by the Company, the
administrative costs of arbitration will be paid by the Company. The fees and
expenses of any witness shall be paid by the Party requiring the presence of
such witness. Each Party shall bear its own costs and expenses in all other
respects. The resolution of any dispute achieved through such arbitration shall
be final and binding and enforceable by a court of competent jurisdiction.

<PAGE>
Exhibit 10.97

                  8.2.  No Jury Trial. NEITHER PARTY SHALL ELECT A TRIAL BY JURY
IN ANY ACTION, SUIT, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR IN ANY WAY
CONNECTED WITH THIS AGREEMENT.

                  8.3.  Personal Jurisdiction. Both parties agree to submit to
the jurisdiction and venue of the state courts in Montgomery County, Maryland as
to matters involving enforcement of this Agreement, including any award under an
arbitration proceeding.

         9. Other Provisions.

                  9.1.  Notices. Any notice or other communication required or
which may be given hereunder shall be in writing and shall be delivered
personally, telegraphed, telexed, sent by facsimile transmission, sent by
nationally recognized overnight courier service such as FedEx or UPS or sent by
certified, registered or express mail, postage paid, and shall be deemed given
when so delivered personally, telegraphed, telexed or sent by facsimile
transmission or, if sent by courier on the second business after delivery by the
courier service or, if mailed, four days after the date of mailing, as follows:

                  (a) if to the Company, to:

                  Gene Logic Inc
                  50 West Watkins Mill Road
                  Gaithersburg, MD 20878
                  Attention: Chairman of the Board of Directors

                  with copies to:

                  Ariel Vannier, Esquire
                  Venable LLP
                  575 7th Street, NW
                  Washington, DC 20004

                  (b) if to the Executive, to:

                  Charles L. Dimmler, III
                  30 Crescent Bluff Ave.
                  Branford, CT 06405

                  Any party may by notice given in accordance with this Section
to the other party designate another address or person for receipt of notices
hereunder.

                  9.2.  Entire Agreement. This Agreement contains the entire
agreement between the parties with respect to the subject matter hereof and
supersedes all prior agreements and understandings, written or oral, with
respect thereto.

                  9.3.  Waivers and Amendments. This Agreement may be amended,
modified, superseded, canceled, renewed or extended, and the terms and
conditions hereof may be waived, only by a written instrument signed by the

<PAGE>
Exhibit 10.97

Executive and a duly authorized officer of the Company (each of the Executive
and Company, in such capacity, a party) or, in the case of a waiver, by the
party waiving compliance. No delay on the part of any party in exercising any
right, power or privilege hereunder shall operate as a waiver thereof, nor shall
any waiver on the part of any party of any right, power or privilege hereunder,
nor any single or partial exercise of any right, power or privilege hereunder,
preclude any other or further exercise thereof or the exercise of any other
right, power or privilege hereunder.

                  9.4.  Governing Law. This Agreement has been negotiated and is
to be performed in the State of Maryland, and shall be governed and construed in
accordance with the laws of the State of Maryland applicable to agreements made
and to be performed entirely within such State, without regard to conflicts of
laws provisions.

                  9.5.  Counterparts. This Agreement may be executed in two or
more counterparts, each of which shall be deemed an original but all of which
together shall constitute one and the same instrument.

                  9.6. Confidentiality. Neither party shall disclose the
contents of this Agreement to any person, firm or entity, except the agents or
representatives of the parties, or except as required by law.

                  9.7.  Word Forms. Whenever used herein, the singular shall
include the plural and the plural shall include the singular. The use of any
gender or tense shall include all genders and tenses.

                  9.8.  Headings. The Section headings have been included for
convenience only, are not part of this Agreement, and are not to be used to
interpret any provision hereof.

                  9.9.  Binding Effect and Benefit. This Agreement shall be
binding upon and inure to the benefit of the parties, their successors, heirs,
personal representatives and other legal representatives. This Agreement may be
assigned by the Company to any entity that buys substantially all of the
Company's assets or to any affiliate of the Company with the consent of the
Executive that shall not be unreasonably withheld. However, the Executive may
not assign this Agreement without the prior written consent of the Company.

                  9.10. Separability. The covenants contained in this Agreement
are separable, and if any court of competent jurisdiction declares any of them
to be invalid or unenforceable, that declaration of invalidity or
unenforceability shall not affect the validity or enforceability of any of the
other covenants, each of which shall remain in full force and effect.

IN WITNESS WHEREOF, the parties, intending to be legally bound, have executed
this Agreement as of the last date of signature below.

                                GENE LOGIC INC.

July 9, 2007                    By: /s/ J. Stark Thompson, Ph.D. (SEAL)
------------                        -----------------------------------
Dated                               J. Stark Thompson, Ph.D.
                                    Chairman of the Board of Directors

                                    EXECUTIVE:

July 9, 2007                    By: /s/ Charles L. Dimmler, III (SEAL)
------------                        ----------------------------------
Dated                               Charles L. Dimmler, III
                                    Chief Executive Officer

<PAGE>
Exhibit 10.97

                                    Exhibit A

For purposes of Section 3.7, the Board of Directors may terminate reimbursement
under this provision at such earlier time as the Company decides on the location
of its corporate headquarters in connection with the strategic reorganization of
the Company.

<PAGE>
Exhibit 10.97

Attachment A

                             Definition of "Cause"

"Cause" shall mean:

i)   commission of an act or an omission that the Board of Directors determines
     would constitute:
     a)   a felony or
     b)   a misdemeanor which, in the Board of Director's reasonable opinion,
          could have a material adverse effect on the Company's business,
          financial condition, prospects or reputation or the Executive's
          performance of his duties, under the laws of the United States or of
          any state
ii)  a material breach by the Executive of any agreement entered into between
     the Executive and the Company including without limitation the violation by
     the Executive of the provisions of the Proprietary Information and
     Inventions Agreement or any restrictive covenants in this Agreement dealing
     with the same subject matter or a material violation of the Company's Code
     of Ethics;
iii) willful misconduct by the Executive or gross negligence of the Executive
     which could reasonably be expected to have a material adverse impact on the
     Company;
iv)  a material failure of the Executive in the performance of the Executive's
     duties provided that, if susceptible of cure as determined by the Board of
     Directors, notice is provided and Executive does not cure such failure
     within fifteen (15) business days after the date of such notice in a manner
     satisfactory to the Board of Directors; or
v)   engagement in any activity that constitutes a material conflict of interest
     with the Company and for which no waiver has been obtained from the Board
     of Directors.

With respect to any criminal act, the Board of Directors may base such a
determination on facts available to it or on an arrest or charges by an
appropriate government authority (without liability if the Executive is
subsequently acquitted or the prosecution is terminated without conviction) and
may, at its option in lieu of immediate termination, suspend the Executive, with
or without pay in the discretion of the Board of Directors, in lieu of immediate
termination in the event of any criminal charges, pending additional
information, criminal conviction or other action enabling a final decision on
whether termination should be "for cause".

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00126-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00126-of-00352.parquet"}]]